Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05882318
Other study ID # 111-6133
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 6, 2023
Est. completion date July 1, 2024

Study information

Verified date January 2024
Source Valencia Technologies Corporation
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this prospective, multi-center, double-blinded randomized controlled is to learn about effectiveness and QOL with eCoin at two different amplitude settings in subjects with urge urinary incontincence (UUI). The main question it aims to answer is: - The reduction in UUI episodes per day on a 3-day voiding diary in both groups after 3 months of therapy Participants will be implanted with the eCoin device and randomized to either a sensory or subsensory stimulation group and complete voiding diaries and patient reported-outcomes through 3 months of therapy.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 50
Est. completion date July 1, 2024
Est. primary completion date May 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Key Inclusion Criteria: 1. Individual with diagnosis of overactive bladder with urgency urinary incontinence - daily UUI with a predominantly urgency component 2. Individual is intolerant of or has an inadequate response to any of anticholinergics, ß3-adrenoceptor agonists, onabotulinumtoxinA, or who have undergone percutaneous tibial nerve stimulation (PTNS). 3. Individual is determined to be a suitable surgical candidate by physician. Key Exclusion Criteria: 1. Individual is not appropriate for eCoin therapy based upon the US FDA-approved IFU requirements. 2. Individual has predominantly stress urinary incontinence (greater than 1/3 of leaks on baseline diary are stress). 3. Individual has clinically significant bladder outlet obstruction. 4. Individual has an active urinary tract infection at time of enrollment or has had four or more symptomatic UTI's in the last 12 months. 5. Individual has significant lower urinary tract pain or has been diagnosed with interstitial cystitis or bladder pain syndrome that is actively being managed. 6. Individual has post void residual greater than 200 cc. 7. Individual has an active diagnosis of bladder, urethral, or prostate cancer. 8. Individual has had a prior anti-stress incontinence surgery within the last year. 9. Individual has uncontrolled diabetes mellitus (Hemoglobin A1C>7). 10. Individual is neutropenic or immune-compromised. 11. Individual has lower extremity pathology such as: 1. Previous surgery and/or significant scarring at the planned implant location 2. Ongoing dermatologic condition at the implant site, including but not limited to dermatitis and autoimmune disorders 3. Clinically significant peripheral neuropathy in the lower extremities 4. Pitting edema at the implant location (= 2+ is excluded) 5. Inadequate skin integrity or any evidence of an infection or inflammation in either lower leg 6. Moderate to severe varicose veins 7. Open wounds or recent trauma 8. Arterial and/or vasculitis disease in the lower extremities 9. Chronic venous insufficiency with a history of skin change (hyperpigmentation, lipodermatosclerosis, ulceration) in the ankle region 12. Individual has neurogenic bladder dysfunction. 13. Individual is aware that he or she will need an MRI scan other than a head/neck/shoulder MRI during the study period. 14. Any condition that, in the investigator's opinion, would preclude participation in the study (e.g., comorbidity that places subject at increased risk for surgical intervention, medical condition that may increase the risk associated with study participation or may interfere with interpretation of study results, inability to adhere to the visit schedule, such as morbid obesity, clotting or bleeding disorder)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
eCoin Peripheral Neurostimulator System
The eCoin device is a leadless, coin-sized tibial neurostimulator for treatment of urgency urinary incontinence. It emits a dome-shaped electrical field to deliver low-duty cycle stimulation to the tibial nerve. The device is to be implanted under local anesthetic in the lower leg, and once activated delivers automatic 30-minute treatment sessions without the need for patient management.

Locations

Country Name City State
United States Institute for Female Pelvic Medicine Allentown Pennsylvania
United States The Iowa Clinic Ankeny Iowa
United States Genesis Research Downey California
United States Urology Associates of Central California Fresno California
United States Adult & Pediatric Urology P.C. Omaha Nebraska
United States Associated Urologists of North Carolina Raleigh North Carolina
United States Cypress Medical Research Center Wichita Kansas

Sponsors (1)

Lead Sponsor Collaborator
Valencia Technologies Corporation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction in UUI Episodes The primary endpoint is to explore the effect of two different eCoin amplitude settings on the reduction of UUI episodes per day on a 3-day voiding diary 3 months post-activation
Secondary Quality of Life with OABq Change from baseline in the patient reported quality of life as assessed by the Health Related Quality of Life (HRQL) portion of the Overactive Bladder questionnaire (OABq) survey
Higher scores on the HRQL portion indicate better quality of life.
2, 3 and 4 months post-activation
Secondary Patient Satisfaction Improvement from baseline of patient satisfaction with UUI symptoms as gathered from patient satisfaction surveys 2, 3 and 4 months post-activation
Secondary Reduction in UUI Episodes Reduction from baseline in the number of urgency urinary incontinence episodes per day on a 3-day voiding diary (72 hours) 2 and 4 months post-activation
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03556891 - Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence N/A
Active, not recruiting NCT04936464 - Transcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence N/A
Completed NCT04470765 - Transcutaneous Tibial Nerve Stimulation: the ZIDA Device Equivalence N/A
Recruiting NCT05415865 - The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder Phase 3
Recruiting NCT05099419 - Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency Incontinence Early Phase 1
Recruiting NCT05874375 - UCon Treatment of Overactive Bladder (OAB) in Males N/A
Active, not recruiting NCT05241379 - AURA-2: Augmenting Urinary Reflex Activity N/A
Completed NCT02657057 - Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB N/A
Withdrawn NCT00773552 - Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder Phase 4
Recruiting NCT04752709 - Efficacy of Surface Electrical Stimulation for Urge Urinary Incontinence in Women N/A
Recruiting NCT03755089 - Oral vs Intravesical Analgesia for Office Bladder Botox Injections Phase 4
Terminated NCT03687164 - Group Medical Visits for Latina Women With Urgency Urinary Incontinence N/A
Withdrawn NCT03697954 - Direct Full-stage Implantation of Sacral Neuromodulation
Completed NCT00337558 - A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) Phase 4
Completed NCT03180372 - Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence N/A
Completed NCT05783219 - Lidocaine Patches Prior to Percutaneous Nerve Evaluation Phase 2
Active, not recruiting NCT05308979 - Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial Phase 4
Completed NCT03672461 - A Group-Based Therapeutic Yoga Intervention for Urinary Incontinence in Ambulatory Older Women N/A
Completed NCT01391780 - Pelvic Floor Muscle Evaluation in Women With Stress Urinary and Urgency Urinary Incontinence N/A
Completed NCT03655054 - eCoin for OAB Feasibility Follow-on Study N/A